Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, Zasloff M, Marshall JL, Shetty K, Johnson L, Mishra L, He AR.

Oncogene. 2009 Feb 19;28(7):961-72. doi: 10.1038/onc.2008.448. Epub 2009 Jan 12.

2.

Cancer stem cells and hepatocellular carcinoma.

Yao Z, Mishra L.

Cancer Biol Ther. 2009 Sep;8(18):1691-8. Review.

3.

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.

Subramaniam A, Shanmugam MK, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G.

Biochim Biophys Acta. 2013 Jan;1835(1):46-60. doi: 10.1016/j.bbcan.2012.10.002. Epub 2012 Oct 26. Review.

PMID:
23103770
4.

Inhibiting TGF-β signaling in hepatocellular carcinoma.

Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S.

Biochim Biophys Acta. 2011 Apr;1815(2):214-23. doi: 10.1016/j.bbcan.2010.11.004. Epub 2010 Dec 1. Review.

PMID:
21129443
5.

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.

Neuzillet C, de Gramont A, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E.

Oncotarget. 2014 Jan 15;5(1):78-94. Review.

6.

[Review on the associations of signal transducer and activators of transcription 3 with hepatocellular carcinoma].

Xie JX, Gao QJ.

Zhonghua Yu Fang Yi Xue Za Zhi. 2016 May;50(5):468-72. doi: 10.3760/cma.j.issn.0253-9624.2016.05.017. Review. Chinese.

PMID:
27141908
7.

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra L.

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):530-8. doi: 10.1038/nrgastro.2012.114. Epub 2012 Jun 19. Review.

8.

Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.

Chen SR, Qiu HC, Hu Y, Wang Y, Wang YT.

Phytother Res. 2016 Jun;30(6):863-77. doi: 10.1002/ptr.5594. Epub 2016 Feb 15. Review.

PMID:
26879574
9.

Role of estrogen in hepatocellular carcinoma: is inflammation the key?

Shi L, Feng Y, Lin H, Ma R, Cai X.

J Transl Med. 2014 Apr 8;12:93. doi: 10.1186/1479-5876-12-93. Review.

Supplemental Content

Support Center